StudyRareStudyRare

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)

Log in to star

Last updated Nov 4, 2026

Log in to add personal notes on this page.

A young adult with progressive external ophthalmoplegia has severe GI dysmotility, cachexia, and peripheral neuropathy.

AR; TYMP (thymidine phosphorylase, a nuclear-encoded enzyme of nucleoside breakdown). Biallelic loss-of-function variants; the toxic nucleoside excess damages mtDNA, so a nuclear gene produces a mitochondrial disease.

Thymidine phosphorylase breaks thymidine down to thymine and 2-deoxyribose 1-phosphate. When it fails, thymidine and deoxyuridine build up in plasma and tissues, which unbalances the mitochondrial nucleotide pools: too much dTTP, too little dCTP. Replication of mtDNA becomes unstable, and over time tissues accumulate mtDNA deletions, duplications, and depletion. Nuclear DNA is spared, for three reasons:

  1. The mitochondrial nucleotide pool is sequestered inside the mitochondria.
  2. mtDNA depends more on thymidine salvage than nuclear DNA, which relies on new thymidine synthesis.
  3. mtDNA has limited repair capacity.

Because mtDNA replicates throughout life, oxidative phosphorylation fails progressively and tissues across the body develop abnormalities over time. Variants that leave less severe enzyme dysfunction, such as p.Val208Met, give late onset.

Lowering thymidine is the logic of treatment. Allogeneic stem cell transplantation supplies enzyme and nearly corrects the nucleoside imbalance in blood, with clinical improvement after engraftment, but its morbidity and mortality limit its use.

thymidine phosphorylaseTYMP; breaks them down, keepingthe pools balancedMNGIEDNA polymerase gammaPOLG; the main polymerase thatreplicates and repairs mtDNA;proofreads the copyPOLG-related disordersthymidine anddeoxyuridinebalanced nucleotidepoolsreplicated mtDNA
Excerpt from mitochondrial DNA maintenance and translation. See the full pathway.
thymidine phosphorylaseTYMP; pyrimidine breakdownMNGIEthymidinethymine + 2-deoxy-ribose 1-phosphate
Excerpt from purine and pyrimidine metabolism. See the full pathway.

Part of mitochondrial DNA maintenance and translation.

Pyrimidine nucleoside catabolism, which protects the mitochondrial nucleotide pool.

thymidine and deoxyuridine → thymidine phosphorylase (the block) → thymine + 2-deoxyribose 1-phosphate; excess thymidine → excess mitochondrial dTTP, scarce dCTP → unstable mtDNA replication

  • Accumulates: thymidine and deoxyuridine in plasma (the biochemical hallmark); in muscle, mtDNA depletion and deletions.
  • Missing: thymidine phosphorylase activity (markedly reduced in leukocytes), and over time normal mtDNA and oxidative phosphorylation.
  • GI dysmotility (gastroparesis, pseudo-obstruction)
  • Cachexia
  • PEO, ptosis
  • Peripheral neuropathy
  • Leukoencephalopathy
  • Markedly reduced thymidine phosphorylase activity in leukocytes
  • Elevated plasma thymidine and deoxyuridine (the biochemical hallmark)
  • Brain MRI: diffuse leukoencephalopathy; muscle shows secondary mtDNA depletion/deletions
  • Confirmation: TYMP molecular testing
  • Largely supportive: nutritional support (often parenteral) for cachexia and GI failure, pain and dysmotility management
  • Allogeneic HSCT can restore thymidine phosphorylase activity; liver transplant and enzyme/carrier-erythrocyte replacement are being studied
  • Nuclear gene (TYMP), autosomal recessive: standard 25% sibling recurrence risk (contrast with maternally inherited mtDNA disorders)

MNGIE = the diagnosis: the name encodes all the key features: Mitochondrial NeuroGastroIntestinal Encephalomyopathy. GI dysmotility and cachexia dominate the presentation.

TYMP = thymidine phosphorylase: deficiency causes excess thymidine (and deoxyuridine), which leads to mitochondrial DNA instability. Patients are often initially misdiagnosed with anorexia nervosa due to severe cachexia. Treatment options include BMT, ERT, and liver transplant.

This overview encodes the gene ("TYME is MoNEy"), the mtDNA consequences ("Many Nucleotides are GonE"), and the demyelinating polyneuropathy ("MyeliN is GonE") affecting cranial nerves, peripheral nerves, and GI nerves.

MNGIE comprehensive mnemonic: AR mutation in TYMP, "TYME is MoNEy" for gene, mtDNA deletions and depletion, demyelinating polyneuropathy affecting CN 3/4/6/8, peripheral nerves, and GI nerves
MNGIE comprehensive mnemonic: AR mutation in TYMP, "TYME is MoNEy" for gene, mtDNA deletions and depletion, demyelinating polyneuropathy affecting CN 3/4/6/8, peripheral nerves, and GI nerves

Reference Links